AGEs impair Kv channel-mediated vasodilation of coronary arteries by activating the NF-κB signaling pathway in ZDF rats

Biomed Pharmacother. 2019 Dec:120:109527. doi: 10.1016/j.biopha.2019.109527. Epub 2019 Oct 17.

Abstract

Excessive formation of advanced glycation end products (AGEs) impairs voltage-gated potassium (Kv) channels in rat coronary artery smooth muscle cells (CSMCs), resulting in weakened Kv-mediated coronary vasodilation. We hypothesized that induction of the nuclear factor-κB (NF-κB) signaling pathway by AGEs plays a significant role in the regulation of Kv channel-mediated vasodilation in Zucker diabetic fatty (ZDF) rats. Assays of mRNA transcripts, protein expression, and intracellular localization as well as patch-clamp experiments in cultured CSMCs revealed that AGEs significantly induced activation of the NF-κB signaling pathway, reduced Kv1.2/1.5 expression, and inhibited Kv currents. In addition, silencing of the receptor for AGEs (RAGE) or p65 with siRNA and treatment with alagrebrium (ALA) or pyrrolidine dithiocarbamate (PDTC) alleviated the AGE-induced impairment of Kv channels in CSMCs. Compared with Zucker lean (ZL) rats, the amount of AGEs, RAGE protein expression, and NF-κB activity in coronary arteries were higher in ZDF rats; whereas Kv1.2/1.5 expression was significantly lower in ZDF rats. Reduced Kv1.2/1.5 expression in coronary arteries and impaired Kv-mediated coronary relaxation tested by wire myography in ZDF rats were markedly improved by treatment with aminoguanidine (AG), ALA, or PDTC. These effects were accompanied by diminished NF-κB activity, inflammation, and oxidative stress. Taken together, these results indicate that an increased interaction between AGEs and RAGE in diabetic rats leads to impaired Kv channel-mediated coronary vasodilation. Moreover, activation of the NF-κB signaling pathway and a subsequent increase of inflammation and oxidative stress may play an important role in AGE-induced impairment of coronary vasodilation in diabetes.

Keywords: Advanced glycation end products; Coronary vasodilation; NF-κB signaling pathway; Voltage-gated potassium channels; Zucker diabetic fatty rats.

MeSH terms

  • Animals
  • Coronary Vessels / drug effects
  • Coronary Vessels / pathology
  • Coronary Vessels / physiopathology*
  • Gene Silencing / drug effects
  • Glycation End Products, Advanced / blood
  • Glycation End Products, Advanced / toxicity*
  • Heart Function Tests
  • Inflammation / blood
  • Inflammation / pathology
  • Male
  • Models, Biological
  • Myocytes, Smooth Muscle / drug effects
  • Myocytes, Smooth Muscle / metabolism
  • NF-kappa B / metabolism*
  • Oxidative Stress / drug effects
  • Potassium Channels, Voltage-Gated / metabolism*
  • Protein Binding / drug effects
  • Rats, Zucker
  • Receptor for Advanced Glycation End Products / metabolism
  • Signal Transduction*
  • Transcription Factor RelA / metabolism
  • Tyrosine / analogs & derivatives
  • Tyrosine / metabolism
  • Vasodilation / drug effects*

Substances

  • Glycation End Products, Advanced
  • NF-kappa B
  • Potassium Channels, Voltage-Gated
  • Receptor for Advanced Glycation End Products
  • Transcription Factor RelA
  • 3-nitrotyrosine
  • Tyrosine